Filgrastim

Filgrastim
Product Description

Filgrastim, Neupogen, G-CSF, Indicated to neutropenia, Formulated bulk liquid, l  Injection (ampoule/PFS/vial) 75µg/unit, 150µg/unit, 300µg/unit, 450µg/unit

Hangzhou Jiuyuan Gene Engineering Co.,Lt

  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    121181-53-1
  • Details
    75mcg, 150mcg, 300mcg, 450mcg, 480mcg
  • Selling Points
    International Approvals/Standards; Product Performance; Quality Service; Reputation; Small Orders Accepted; we have phase I, II and III clinical data. Launched in China since 1996.
  • Model
    ampoule, vial and PFS
  • Supplied from
    China
  • Measured In
    piece

Hangzhou Jiuyuan Gene Engineering Co.,Lt

  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from Hangzhou Jiuyuan Gene Engineering Co.,Lt (16)

  • Recombinant Human Bone Morphogenetic Protein-2

    Product Recombinant Human Bone Morphogenetic Protein-2

    rhBMP-2, a new bone repair material,registered as an implanted medical device, Active pharmaceutical ingredient (API),Tablet (vial): 1mg/vial

  • Recombinant Human Interleukin-11

    Product Recombinant Human Interleukin-11

    rhIL-11,  Oprelvekin, a drug to increase platelet count, l  Lyophilized powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial


  • Recombinant Human Interleukin-11

    Product Recombinant Human Interleukin-11

    rhIL-11 (Oprelvekin), a drug to increase platelet count,Lyophilized powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial

  • rhBMP-2

    Product rhBMP-2

    a new bone repairing materialbrhrbrrecombinant human Bone Morphogenetic Protein-2, bone reparing, BMP-2, BMP
  • semaglutide

    Product semaglutide

    diabetes (recombinant route),  API
  • Semaglutide

    Product Semaglutide

    Diabetes and Obesity
  • Fosaprepitant dimeglumine

    Product Fosaprepitant dimeglumine

    cancerbrhrbrEmend, CAS number: 265121-04-8
  • Dulaglutide

    Product Dulaglutide

    diabetes (recombinant route), API
  • Fulvestrant

    Product Fulvestrant

    an anti-cancer drug, Bulk and injection (PFS): 250mg in 5ml

  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API) , Injection (ampoule): 0.25mg/5ml


  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API),Injection (ampoule): 0.25mg/5ml

  • Palonosetron Hydrochloride

    Product Palonosetron Hydrochloride

    anti-emesis after chemotherapy or radiotherapybrhrbrPalonosetron, Aloxi